Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND & AIMS: Many patients with gastroparesis are prescribed opioids for pain control, but indications for opioid prescriptions and the relationship of opioid use to gastroparesis manifestations are undefined. We characterized associations of use of potent vs weaker opioids and presentations of diabetic and idiopathic gastroparesis. METHODS: We collected data on symptoms, gastric emptying, quality of life, and health care resource use from 583 patients with gastroparesis (>10% 4-h scintigraphic retention) from the National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Consortium, from January 2007 through November 2016. Patients completed medical questionnaires that included questions about opioid use. The opioid(s) were categorized for potency relative to oral morphine. Symptom severities were quantified by Patient Assessment of Upper Gastrointestinal Disorders Symptoms questionnaires. Subgroup analyses compared patients on potent vs weaker opioids and opioid effects in diabetic vs idiopathic etiologies. RESULTS: Forty-one percent of patients were taking opioids; 82% of these took potent agents (morphine, hydrocodone, oxycodone, methadone, hydromorphone, buprenorphine, or fentanyl). Abdominal pain was the reason for prescription for 61% of patients taking opioids. Mean scores for gastroparesis, nausea/vomiting, bloating/distention, abdominal pain, and constipation scores were higher in opioid users (P ≤ .05). Opioid use was associated with greater levels of gastric retention, worse quality of life, increased hospitalization, and increased use of antiemetic and pain modulator medications compared with nonusers (P ≤ .03). Use of potent opioids was associated with worse gastroparesis, nausea/vomiting, upper abdominal pain, and quality-of-life scores, and more hospitalizations compared with weaker opioids (tapentadol, tramadol, codeine, or propoxyphene) (P ≤ .05). Opioid use was associated with larger increases in gastric retention in patients with idiopathic vs diabetic gastroparesis (P = .008). CONCLUSIONS: Opioid use is prevalent among patients with diabetic or idiopathic gastroparesis, and is associated with worse symptoms, delays in gastric emptying, and lower quality of life, as well as greater use of resources. Potent opioids are associated with larger effects than weaker agents. These findings form a basis for studies to characterize adverse outcomes of opioid use in patients with gastroparesis and to help identify those who might benefit from interventions to prevent opioid overuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opioids in chronic non-cancer pain: systematic review of efficacy and safety
Kalso, E., Edwards, J. E., Moore, A. R., & McQuay, H. J. (2004) · Pain · doi:10.1016/j.pain.2004.09.019 · Cited by 1,216
The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013
Florence, C. S., Zhou, C., Luo, F., & Xu, L. (2016) · Medical Care · doi:10.1097/mlr.0000000000000625 · Cited by 1,152
Rentz, A. M., Kahrilas, P., Stanghellini, V., Tack, J., Talley, N. J., De la loge, C., Trudeau, E., Dubois, D., & Revicki, D. A. (2004) · Quality of Life Research · doi:10.1007/s11136-004-9567-x · Cited by 406
Different faces of gastroparesis
Bielefeldt, K., Raza, N., & Zickmund, S. L. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.6052 · Cited by 71
Cited by
ACG Clinical Guideline: Gastroparesis
Camilleri, M., Kuo, B., Nguyen, L., Vaughn, V. M., Petrey, J., Greer, K., Yadlapati, R., & Abell, T. L. (2022) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001874 · Cited by 332
Self-citationGastroparesis: a turning point in understanding and treatment
Grover, M., Farrugia, G., & Stanghellini, V. (2019) · Gut · doi:10.1136/gutjnl-2019-318712 · Cited by 256
Self-citationPharmacologic treatments for gastroparesis
Camilleri, M., & Jencks, K. J. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100019 · Cited by 14
Nakamura, A., Yasufuku, K., Shimada, S., Aritomi, H., Furue, Y., Chiba, H., Muramoto, M., Takase, K., Koike, K., Matsumoto, T., et al. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135177 · Cited by 9
Metadata
- Authors
- Hasler, W. L., Wilson, L. A., Nguyen, L. A., Snape, W. J., Abell, T. L., Koch, K. L., McCallum, R. W., Pasricha, P. J., Sarosiek, I., Farrugia, G., Grover, M., Lee, L. A., Miriel, L., Tonascia, J., Hamilton, F. A., Parkman, H. P., Pasricha, P. J., Clarke, J., Kim, Y., Nguyen, L., Ullah, N., Snape, W., DeVole, N., Greene, M., Lee, C., Ponsetto, C., Shetler, K., Parkman, H. P., Kantor, S., Lytes, V., Palit, A., Simmons, K., McCallum, R. W., Hejazi, R., Roeser, K., Sarosiek, I., Vasquez, D., Vega, N., Abell, T., Beatty, K., Hatter, L., Howard, R., Nowotny, L., Tang, S., Amin, O. S., Henry, O., Kedar, A., McNair, V., Pruett, S., Smith, M., Spree, D., Hasler, W., Castle, M., Coleski, R., Wootten, S., Koch, K., Baxter, L., Brown, A., Culler, S., Hooker, J., Stuart, P., Farrugia, G., Grover, M., Bernard, C., Calles-Escandon, J., Serrano, J., Hamilton, F., James, S., Torrance, R., Van Raaphorst, R., Tonascia, J., Belt, P., Hallinan, E. C., Colvin, R., Donithan, M., Green, M., Isaacson, M., Kim, W., Lee, L., May, P., Miriel, L., Sternberg, A., Van Natta, M., Vaughn, I., Wilson, L., & Yates, K.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 17
- Issue
- 7
- Pages
- 1285-1294.e1
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2897597485
- Cited by
- 84
- References
- 4
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis. https://app.cochat.ai/papers/10.1016/j.cgh.2018.10.013
- The paper
- Hasler, W. L., Wilson, L. A., Nguyen, L. A., Snape, W. J., Abell, T. L., Koch, K. L., McCallum, R. W., Pasricha, P. J., Sarosiek, I., Farrugia, G., Grover, M., Lee, L. A., Miriel, L., Tonascia, J., Hamilton, F. A., Parkman, H. P., Pasricha, P. J., Clarke, J., Kim, Y., . . . Yates, K. (2019). Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2018.10.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.